Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares (FLSC) Stock Analysis

AI analysis of Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares (FLSC)

Hold

Frazier Life Sciences Acquisition Corp. II is currently trading at $10.16, which is 25.6% of its 52-week range between $10.00 and $10.62. The stock has shown a year-to-date change of +1.60%, indicating some stability. However, with a lack of significant insider or hedge fund activity and a neutral market context, it may be prudent to hold rather than buy at this time. The main risk is the recent 5-day change of -1.17%, suggesting potential downward momentum.

Valuation Metrics

The current forward P/E ratio for Frazier Life Sciences Acquisition Corp. II Class A Ordinary Shares (FLSC) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E

Current P/E

0.00

Forward EV/EBITDA

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Forward P/S

5Y Average P/S

Current P/S

0.00

FLSC FAQ — answered by Alphio AI

Frazier Life Sciences Acquisition Corp. II is currently trading at $10.16, which is 25.6% of its 52-week range between $10.00 and $10.62. The stock has shown a year-to-date change of +1.60%, indicating some stability. However, with a lack of significant insider or hedge fund activity and a neutral market context, it may be prudent to hold rather than buy at this time. The main risk is the recent 5-day change of -1.17%, suggesting potential downward momentum.